comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 04:07:33 - browse：46

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Twill hunts for pharma partner to market its depression app

Wikipedia

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

International team creates first chimeric human

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Biden administration sends mixed signals on US soldier who crossed into North Korea

Study: Hearing aids may slow cognitive decline in those at risk

Why you get paid to donate plasma but not blood

leisure time

comprehensive

focus

Walensky prepares to leave CDC — and Congress — behind

International team creates first chimeric human

State Dept. review finds Biden bears some blame for Afghanistan failures

ALS groups 'won't be played again' by the FDA, drug sponsors

ChatGPT in medicine: STAT answers readers' burning questions

International team creates first chimeric human

Trump demands the U.S. pay no more for drugs than other countries … again

More hospitals are billing patients as online messages surge

At least 13 dead in Texas as scorching temps continue

Kenai launches with $82 million for Parkinson’s stem cell therapy

explore

In search for therapies for solid tumors, companies turn to claudin

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

15 die by electrocution after transformer explodes in northern India

Why getting cancer drugs just got harder for rural patients

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

focus

Wikipedia

focus

knowledge